Central Nervous System

SH 03 - Science Highlights 03 - Central Nervous System (CNS) Cancer

9/17/2019
8:00 AM - 8:30 AM
Location: Room W181

Session Type: Science Highlights
0.50 AMA PRA Category 1 Credits™
0.50 CAMPEP Credits

This session will review the most impactful abstracts from the CNS Track
* Comprehensive Prognostic and Predictive Molecular Subgroup Analysis within the High-risk Treatment Arms of NRG Oncology/RTOG 9802: a Phase III Trial of RT versus RT + PCV in High-risk Low-grade Gliomas, E.H. Bell
* Microstructural Injury to Perisylvian White Matter Predicts Language Decline After Brain Radiotherapy [RT]: Quantitative Analysis of a Prospective Trial, M.D. Tibbs
* Diffusion imaging biomarkers of corpus callosum injury and dose-dependent volumetric changes correlate with attention and processing speed changes after brain radiotherapy, M.P. Huynh-Le
* Significant preservation of neurocognitive function (NCF) and patient-reported symptoms with hippocampal avoidance (HA) during whole-brain radiotherapy (WBRT) for brain metastases: Final results of NRG Oncology CC001, V. Gondi
* Radiosurgery Compared To External Beam Radiotherapy for Localized Spine Metastasis: Phase III Results of NRG Oncology/RTOG 0631, S. Ryu
* Randomized Phase II Trial of Re-Irradiation and Concurrent Bevacizumab versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma (NRG Oncology/RTOG 1205):Initial Outcomes and RT Plan Quality Report, C. Tsien

Presentations:


Assets

SH 03 - Science Highlights 03 - Central Nervous System (CNS) Cancer



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SH 03 - Science Highlights 03 - Central Nervous System (CNS) Cancer